Liaoning Cheng Da Co., Ltd. (SHA:600739)

Market Cap	18.24B +25.6%
Revenue (ttm)	9.43B -12.4%
Net Income	940.13M +100.4%
EPS	0.62 +99.4%
Shares Out	1.52B
PE Ratio	19.46
Forward PE	n/a
Dividend	0.02 (0.17%)
Ex-Dividend Date	Jul 30, 2025

Volume	8,698,226
Average Volume	11,802,380
Open	11.97
Previous Close	11.98
Day's Range	11.85 - 12.05
52-Week Range	10.18 - 13.58
Beta	0.79
RSI	56.25
Earnings Date	Apr 25, 2026

About Liaoning Cheng Da

Liaoning Cheng Da Co., Ltd. engages in biopharmaceutical, financial investment, supply chain, energy development, and other businesses in China and internationally. The company is involved in the import and export of textiles, and clothing, as well as the trade of bulk commodities, such as coal, steel, and aquatic products; and oil shale mining, shale oil production, and sale business. It also offers financial service enterprises including securities, insurance, and funds; rabies vaccines for human use and inactivated Japanese encephalitis vacc...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1991
• Employees: 3,317
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600739

Financial Performance

In 2025, Liaoning Cheng Da's revenue was 9.90 billion, a decrease of -12.29% compared to the previous year's 11.29 billion. Earnings were 736.55 million, an increase of 251.48%.